IllnessPrenatally abnormal kidneys / urinary tract, differential diagnosis
Summary
Comprehensive differential diagnostic panel for Prenatally abnormal kidneys / urinary tract containing 35 expert opinion-curated genes and altogether 106 curated genes according to the clinical signs
224,2 kb (Extended panel: incl. additional genes)
- Amniotic fluid (after amnocentesis)
- Chorionic villus
- Umbilical cord blood
NGS +
[Sanger]
Gene panel
Selected genes
Name | Exon Length (bp) | OMIM-G | Referenz-Seq. | Heredity |
---|---|---|---|---|
HNF1B | 1674 | NM_000458.4 | AD | |
NPHP3 | 3993 | NM_153240.5 | AR | |
PKHD1 | 12225 | NM_138694.4 | AR | |
RPGRIP1L | 3948 | NM_015272.5 | AR | |
ACE | 3921 | NM_000789.4 | AR | |
ACTG2 | 1131 | NM_001615.4 | AD | |
ANOS1 | 2043 | NM_000216.4 | XLR | |
BMP4 | 1227 | NM_001202.6 | AD | |
BNC2 | 3297 | NM_017637.6 | AD | |
CHD7 | 8994 | NM_017780.4 | AD | |
CHRNA3 | 1518 | NM_000743.5 | AR | |
CRB2 | 3858 | NM_173689.7 | AR | |
DHCR7 | 1428 | NM_001360.3 | AR | |
DSTYK | 2790 | NM_015375.3 | AD | |
EYA1 | 1779 | NM_000503.6 | AD | |
FANCB | 2580 | NM_001018113.3 | XLR | |
FGF20 | 636 | NM_019851.3 | AR | |
FOXC2 | 1506 | NM_005251.3 | AD | |
FRAS1 | 12039 | NM_025074.7 | AR | |
FREM1 | 6540 | NM_144966.7 | AR | |
FREM2 | 9510 | NM_207361.6 | AR | |
GATA3 | 1335 | NM_001002295.2 | AD | |
GLI3 | 4743 | NM_000168.6 | AD | |
GPC3 | 1743 | NM_004484.4 | XLR | |
GRIP1 | 3231 | NM_021150.4 | AR | |
HOXA13 | 1167 | NM_000522.5 | AD | |
HPSE2 | 1605 | NM_001166244.1 | AR | |
ITGA8 | 3192 | NM_003638.3 | AR | |
JAG1 | 3657 | NM_000214.3 | AD | |
KDM6A | 4206 | NM_021140.4 | XL | |
KMT2D | 16614 | NM_003482.4 | AD | |
KYNU | 924 | NM_001032998.2 | AR | |
LIFR | 3294 | NM_002310.6 | AD | |
LMOD1 | 1806 | NM_012134.3 | AR | |
LRIG2 | 3198 | NM_014813.3 | AR | |
LRP4 | 5718 | NM_002334.4 | AR | |
MYH11 | 5919 | NM_002474.3 | AR | |
MYL9 | 522 | NM_006097.5 | AR | |
MYLK | 5745 | NM_053025.4 | AR | |
MYOCD | 2961 | NM_001146312.3 | AD, AR | |
NIPBL | 8415 | NM_133433.4 | AD | |
NR0B1 | 1413 | NM_000475.5 | XL | |
NRIP1 | 3477 | NM_003489.4 | AD | |
PAX2 | 1254 | NM_003987.5 | AD | |
PBX1 | 1293 | NM_002585.4 | AD | |
REN | 1221 | NM_000537.4 | AR, AD | |
RET | 3345 | NM_020975.6 | AD, AR | |
ROBO2 | 4185 | NM_001128929.3 | AD | |
ROR2 | 2832 | NM_004560.4 | AD, AR | |
RRM2B | 1272 | NM_015713.5 | AR | |
SALL1 | 3975 | NM_002968.3 | AD | |
SALL4 | 3162 | NM_020436.5 | AD | |
SAMD9 | 4770 | NM_001193307.2 | AD | |
SIX1 | 855 | NM_005982.4 | AD | |
SIX5 | 2220 | NM_175875.5 | AD | |
SLC12A1 | 3300 | NM_000338.3 | AR | |
SOX17 | 1245 | NM_022454.4 | AD | |
STRA6 | 2004 | NM_001142617.2 | AR | |
TBC1D1 | 3480 | NM_001253912.2 | AD | |
TBX18 | 1824 | NM_001080508.3 | AD | |
TFAP2A | 1296 | NM_001032280.3 | AD | |
TRAP1 | 2115 | NM_016292.3 | AR | |
VIPAS39 | 1482 | NM_022067.4 | AR | |
VPS33B | 1854 | NM_018668.5 | AR | |
WNT4 | 1056 | NM_030761.5 | AD, AR | |
WNT5A | 1143 | NM_003392.7 | AD | |
ZIC3 | 1404 | NM_003413.4 | XLR |
Informations about the disease
Congenital abnormalities of kidneys + urinary tract are the most common sonographically identified malformations prenatally. Obstructive uropathies account for the majority of cases. The aim of prenatal diagnosis + management is to detect those anomalies having impact on prognosis of the affected child, requiring early postnatal evaluation/treatment to minimize adverse outcomes.
- Alias: Congenital Anomalies of the Kidney and Urinary Tract - CAKUT
- Alias: Prenatally unusual ultrasound findings in urinary tract
- Alias: Renal or urinary tract malformation
- Allelic: Bone marrow failure [panelapp] (EXOC3L)
- Allelic: Branchiootic syndrome 3 (SIX1)
- Allelic: Dandy-Walker malformation [panelapp] (EXOC3L)
- Allelic: Deafness, AD 23 (SIX1)
- Allelic: Deafness, AD 80 (GREB1L)
- Allelic: Diabetes mellitus, noninsulin-dependent (HNF1B)
- Allelic: Diarrhea 10, protein-losing enteropathy type (PLVAP)
- Allelic: Hydroxykynureninuria (KYNU)
- Allelic: Hypertension, essential, susceptibility to (AGT)
- Allelic: Hyperuricemic nephropathy, familial juvenile 2 (REN)
- Allelic: Manitoba oculotrichoanal syndrome (FREM1)
- Allelic: Nephronophthisis 3 (NPHP3)
- Allelic: Renal cell carcinoma (HNF1B)
- Allelic: Retinitis pigmentosa 23 (OFD1)
- Allelic: Spermatogenic failure 72 (WDR19)
- Allelic:Preeclampsia, susceptibility to (AGT)
- 46XY sex reversal 2, dosage-sensitive (NR0B1)
- Adrenal hypoplasia, congenital (NR0B1)
- Alagille syndrome 1 (JAG1)
- Alagille syndrome 2 (NOTCH2)
- Arthrogryposis, renal dysfunction, + cholestasis 1 (VPS33B)
- Bardet-Biedl syndrome 1 (BBS1)
- Bardet-Biedl syndrome 1, modifier of (ARL6)
- Bardet-Biedl syndrome 1, modifier of (CCDC28B)
- Bardet-Biedl syndrome 10 (BBS10)
- Bardet-Biedl syndrome 11 (TRIM32)
- Bardet-Biedl syndrome 12 (BBS12)
- Bardet-Biedl syndrome 13 (MKS1)
- Bardet-Biedl syndrome 14 (CEP290)
- Bardet-Biedl syndrome 14, modifier of (TMEM67)
- Bardet-Biedl syndrome 15 (WDPCP)
- Bardet-Biedl syndrome 16 (SDCCAG8)
- Bardet-Biedl syndrome 17 (LZTFL1)
- Bardet-Biedl syndrome 18 (BBIP1)
- Bardet-Biedl syndrome 19 (IFT27)
- Bardet-Biedl syndrome 2 (BBS2)
- Bardet-Biedl syndrome 20 (IFT172)
- Bardet-Biedl syndrome 21 (CFAP418)
- Bardet-Biedl syndrome 22 (IFT74)
- Bardet-Biedl syndrome 3 (ARL6)
- Bardet-Biedl syndrome 4 (BBS4)
- Bardet-Biedl syndrome 5 (BBS5)
- Bardet-Biedl syndrome 6 (MKKS)
- Bardet-Biedl syndrome 7 (BBS7)
- Bardet-Biedl syndrome 8 (TTC8)
- Bardet-Biedl syndrome 9 (PTHB1)
- Bartter syndrome, type 1 (SLC12A1)
- Bifid nose with/-out anorectal + renal anomalies (FREM1)
- Bladder dysfunction, autonomic, with impaired pupillary reflex + secondary CAKUT (CHRNA3)
- Branchio-oto-renal syndrome [panelapp] (SIX1)
- Branchiooculofacial syndrome (TFAP2A)
- Branchiootorenal syndrome 1, with/-out cataracts (EYA1)
- Branchiootorenal syndrome 2 (SIX5)
- CAKUT + VACTERL association [panelapp] (TRAP1)
- CAKUT [panelapp] (EXOC3L2)
- CAKUT [panelapp] (PLVAP)
- CAKUT [panelapp] (SLIT2)
- CAKUT [panelapp] (TBC1D1)
- CAKUT syndrome with/-out hearing loss, abnormal ears/developmental delay (PBX1)
- CHARGE syndrome (CHD7)
- COACH syndrome 1 (TMEM67)
- Cenani-Lenz syndactyly syndrome (LRP4)
- Congenital anomalies of kidney + urinary tract 1 (DSTYK)
- Congenital anomalies of kidney + urinary tract 2 (TBX18)
- Congenital anomalies of kidney + urinary tract 3 (NRIP1)
- Congenital anomalies of kidney + urinary tract with/-out hearing loss, abn. ears/dev. delay (PBX1)
- Cornelia de Lange syndrome 1 (NIPBL)
- Cranioectodermal dysplasia 2 (WDR35)
- Cranioectodermal dysplasia 4 (WDR19)
- Duane-radial ray/Okihiro/acrorenoocular syndrome (SALL4)
- Fanconi anemia, complementation group B (FANCB)
- Focal segmental glomerulosclerosis 9 (CRB2)
- Fraser syndrome 1 (FRAS1)
- Fraser syndrome 2 (FREM2)
- Fraser syndrome 3 (GRIP1)
- Glomerulosclerosis, focal segmental, 7 (PAX2)
- Guttmacher syndrome (HOXA13)
- Hajdu-Cheney syndrome (NOTCH2)
- Hand-foot-uterus syndrome (HOXA13)
- Heterotaxy, visceral, 1, XL (ZIC3)
- Hypogonadotropic hypogonadism 1 with/-out anosmia, Kallmann syndrome 1 (ANOS1)
- Hypogonadotropic hypogonadism 5 with/-out anosmia (CHD7)
- Hypoparathyroidism, sensorineural deafness, and renal dysplasia (GATA3)
- Joubert syndrome 10 (OFD1)
- Joubert syndrome 2 (TMEM216)
- Joubert syndrome 28 (MKS1)
- Joubert syndrome 29 (TMEM107)
- Joubert syndrome 34 (B9D2)
- Joubert syndrome 4 (NPHP1)
- Joubert syndrome 6 (TMEM67)
- Joubert syndrome 7 (RPGRIP1L)
- Kabuki syndrome 1 (KMT2D)
- Kabuki syndrome 2 (KDM6A)
- Lymphedema-distichiasis syndrome with renal disease + diabetes mellitus (FOXC2)
- MIRAGE syndrome (SAMD9)
- Meckel syndrome 1 (MKS1)
- Meckel syndrome 10 (B9D2)
- Meckel syndrome 11 (TMEM231)
- Meckel syndrome 12 (KIF14)
- Meckel syndrome 13 (TMEM107)
- Meckel syndrome 14 (TXNDC15)
- Meckel syndrome 2 (TMEM216)
- Meckel syndrome 3 (TMEM67)
- Meckel syndrome 4 (CEP290)
- Meckel syndrome 5 (RPGRIP1L)
- Meckel syndrome 6 (CC2D2A)
- Meckel syndrome 7 (NPHP3)
- Meckel syndrome 8 (TCTN2)
- Meckel syndrome 9 (B9D1)
- Megabladder, congenital (MYOCD)
- Megacystis-microcolon-intestinal hypoperistalsis syndrome 1 (MYLK)
- Megacystis-microcolon-intestinal hypoperistalsis syndrome 2 (MYH11)
- Megacystis-microcolon-intestinal hypoperistalsis syndrome 3 (LMOD1)
- Megacystis-microcolon-intestinal hypoperistalsis syndrome 4 (MYL9)
- Megacystis-microcolon-intestinal hypoperistalsis syndrome 5 (ACTG2)
- Microcephaly, facial dysmorphism, renal agenesis + ambiguous genitalia syndrome (CTU2)
- Microphthalmia, syndromic 6 (BMP4)
- Microphthalmia, syndromic 6 (BNC2)
- Microphthalmia, syndromic 9 (STRA6)
- Mitochondrial DNA depletion syndrome 8A, encephalomyopathic type with renal tubulopathy (RRM2B)
- Mullerian aplasia + hyperandrogenism (WNT4)
- Multinucleated neurons, anhydramnios, renal dysplasia, cereb. hypoplasia, hydranencephaly (CEP55)
- Nephronophthisis 1, juvenile (NPHP1)
- Nephronophthisis 11 (TMEM67)
- Nephronophthisis 13 (WDR19)
- Nephronophthisis 2, infantile (INVS)
- Nephronophthisis 4 (NPHP4)
- Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities (ZMYM2)
- Neurofacioskeletal syndrome with/-out renal agenesis (HS2ST1)
- Orofaciodigital syndrome I (OFD1)
- Pallister-Hall syndrome (GLI3)
- Papillorenal syndrome (PAX2)
- Polycystic kidney disease 1 (PKD1)
- Polycystic kidney disease 2 (PKD2)
- Polycystic kidney disease 3 (GANAB)
- Polycystic kidney disease 4, with/-out hepatic disease (PKHD1)
- Prune belly syndrome (CHRM3)
- RHYNS syndrome (TMEM67)
- Renal agenesis [panelapp] (RET)
- Renal cysts + diabetes syndrome (HNF1B)
- Renal dysplasia [panelapp] (EXOC3L)
- Renal hypodysplasia/aplasia 1 (ITGA8)
- Renal hypodysplasia/aplasia 2 (FGF20)
- Renal hypodysplasia/aplasia 3 (GREB1L)
- Renal tubular dysgenesis (ACE)
- Renal tubular dysgenesis (AGTR1)
- Renal tubular dysgenesis (REN)
- Renal-hepatic-pancreatic dysplasia 1 (NPHP3)
- Robinow syndrome, AD 1 (WNT5A)
- Robinow syndrome, AR (ROR2)
- SERKAL syndrome (WNT4)
- Senior-Loken syndrome 1 (NPHP1)
- Senior-Loken syndrome 3 (SLSN3)
- Senior-Loken syndrome 4 (NPHP4)
- Senior-Loken syndrome 5 (IQCB1)
- Senior-Loken syndrome 6 (CEP290)
- Senior-Loken syndrome 7 (SDCCAG8)
- Senior-Loken syndrome 8 (WDR19)
- Senior-Loken syndrome 9 (TRAF3IP1)
- Short-rib thoracic dysplasia 5 +/- polydactyly (WDR19)
- Short-rib thoracic dysplasia 7 +/- polydactyly (WDR35)
- Simpson-Golabi-Behmel syndrome, type 1 (GPC3)
- Simpson-Golabi-Behmel syndrome, type 2 (OFD1)
- Smith-Lemli-Opitz syndrome (DHCR7)
- Stromme syndrome: intestinal atresia, ocular +/- renal/cardiac abnormalities, microcephaly (CENPF)
- Structural heart defects + renal anomalies syndrome (TMEM260)
- Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome (LIFR)
- Townes-Brocks branchiootorenal-like syndrome (SALL1)
- Townes-Brocks syndrome 1 (SALL1)
- Tubulointerstitial kidney disease, AD, 4 (REN)
- Urofacial syndrome 1 (HPSE2)
- Urofacial syndrome 2 (LRIG2)
- VACTERL association, XL (ZIC3)
- Ventriculomegaly with cystic kidney disease (CRB2)
- Vertebral, cardiac, renal + limb defects syndrome 1 (HAAO)
- Vertebral, cardiac, renal + limb defects syndrome 2 (KYNU)
- Vertebral, cardiac, renal + limb defects syndrome 3 (NADSYN1)
- Vertebral, cardiac, tracheoesophageal, renal + limb defects (WBP11)
- Vesicoureteral reflux 2 (ROBO2)
- Vesicoureteral reflux 3 (SOX17)
- AD
- AR
- XL
- XLR
- Multiple OMIM-Ps
Bioinformatics and clinical interpretation
Test-Stärken
- DAkkS-akkreditiertes Labor
- EU-Richtlinie für IVD in Umsetzung
- Qualitäts-kontrolliert arbeitendes Personal
- Leistungsstarke Sequenzierungstechnologien, fortschrittliche Target-Anreicherungsmethoden und Präzisions-Bioinformatik-Pipelines sorgen für überragende analytische Leistung
- Sorgfältige Kuratierung klinisch relevanter und wissenschaftlich begründeter Gen-Panels
- eine Vielzahl nicht Protein-kodierender Varianten, die in unseren klinischen NGS-Tests mit erfasst werden
- unser strenges Variantenklassifizierungsschema nach ACMG-Kriterien
- unser systematischer klinischer Interpretations-Workflow mit proprietärer Software ermöglicht die genaue und nachvollziehbare Verarbeitung von NGS-Daten
- unsere umfassenden klinischen Aussagen
Testeinschränkungen
- Gene mit eingeschränkter Abdeckung werden gekennzeichnet
- Gene mit kompletten oder partiellen Duplikationen werden gekennzeichnet
- es wird angenommen, dass ein Gen suboptimal abgedeckt ist, wenn >90% der Nukleotide des Gens bei einem Mapping-Qualitätsfaktor von >20 (MQ>20) nicht abgedeckt sind
- die Sensitivität der Diagnostik zur Erkennung von Varianten mit genannten Testeinschränkungen ist möglicherweise begrenzt bei:
- Gen-Konversionen
- komplexe Inversionen
- Balancierte Translokationen
- Mitochondriale Varianten
- Repeat-Expansionen, sofern nicht anders dokumentiert
- nicht kodierende Varianten, die Krankheiten verursachen, die von diesem Panel nicht mit abgedeckt werden
- niedriger Mosaik-Status
- Repeat-Blöcke von Mononukleotiden
- Indels >50bp (Insertionen-Deletionen)
- Deletionen oder Duplikationen einzelner Exons
- Varianten innerhalb von Pseudogenen
- die analytische Sensitivität kann geringer ausfallen werden, wenn die DNA nicht von amedes genetics extrahiert wurde
Laboratory requirement
Die in grün gezeigten Gene sind kuratiert und werden als Gen-Panel untersucht. Eine Erweiterung des Panels (blau gezeigte Gene, jeweils ebenfalls kuratiert) kann auf Anfrage erfolgen. Sofern unter "Erweitertes Panel" ein Minuszeichen angezeigt wird, sind nur Core-/Basis-Gene verfügbar.
Für die Anforderung einer genetischen Untersuchung senden Sie uns bitte die Krankheits-ID auf einem Überweisungsschein. Bitte die Material-Angabe beachten.
Für privat versicherte Patienten empfehlen wir einen Antrag auf Kostenübernahme bei der Krankenversicherung.
Die Untersuchung wird auch für Selbstzahler angeboten.